Implementation issues affecting patient access to Medicare covered pharmaceuticals and biologics, including reimbursement adequacy, Medicare Parts B and D benefit parameters, coverage, and reimbursement requirements, including related provisions in H.R. 5376, the Inflation Reduction Act of 2022 (P.L.117-169): Title 1, Subtitle B - Prescription Drug Pricing Reform: Part 1, Lowering Prices Through Drug Price Negotiation; Part 2, Prescription Drug Inflation Rebates; and Part 3, Part D Improvements and Maximum Out-of-Pocket Cap for Medicare Beneficiaries. Enhance Center for Medicare & Medicaid Innovation quality initiatives and patient access to Medicare Part B covered drugs, including advocacy related to the Most Favored Nation and related demonstration initiatives. 340B Program issues and patient access to pharmaceuticals, including monitor related provisions in Sec. 121, H.R. 2471, Consolidated Appropriations Act, 2022, P.L. 117-103. Coronavirus response efforts, including S. 3799, the PREVENT Pandemics Act, and implementation of related provisions in H.R. 1319, the American Rescue Plan Act (P.L. 117-2). Legislative issues associated with patient access to treatment, including: the CMMI Most Favored Nation and related demonstration initiatives; and step therapy, including related provisions in S. 464/H.R. 2163, the Safe Step Act. Medical Supply Chain, including issues related to a new rating system; targeted action to support the diversification of certain supplies; additional funding to the Strategic National Stockpile (SNS) and more diverse stockpile; increasing flexibility for supply chains. Enhanced FDA reporting and risk mitigation plans for certain medicines, including related provisions in Division F, FDA User Fee Reauthorization Act, of H.R. 6833, providing continuing appropriations for FY 2023. Incentives for antimicrobial and antiviral research and novel product development, including related provisions in H.R. 3932, to establish a program to develop antimicrobial innovations.
MMM - Medicare/Medicaid HCR - Health Issues
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
CAPITOL COUNSEL LLC
700 13th Street NW, 2nd Floor, Washington, DC, 20005, US
DENISE HENRY MORRISEY SHANNON FINLEY SARA FRANKO LUKE HATZIS MARTIN B. GOLD ANN JABLON AARON COHEN ROBERT DIAMOND JEFFREY CARROLL DENISE HENRY MORRISEY SHANNON FINLEY SARA FRANKO LUKE HATZIS MARTIN B. GOLD ANN JABLON AARON COHEN JOSEPH EANNELLO ROBERT DIAMOND JEFFREY CARROLL